BXRX
Income statement / Annual
Last year (2022), Baudax Bio, Inc.'s total revenue was $1.27 M,
an increase of 17.50% from the previous year.
In 2022, Baudax Bio, Inc.'s net income was -$58.80 M.
See Baudax Bio, Inc.’s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
Operating Revenue |
$1.27 M
|
$1.08 M
|
$493,000.00
|
$0.00
|
$0.00
|
$0.00
|
Cost of Revenue |
$7.01 M |
$2.45 M |
$1.73 M |
$0.00 |
$0.00 |
$0.00 |
Gross Profit |
-$5.74 M |
-$1.37 M |
-$1.24 M |
$0.00 |
$0.00 |
$0.00 |
Gross Profit Ratio |
-4.52 |
-1.26 |
-2.51 |
0 |
0 |
0 |
Research and Development
Expenses |
$3.89 M
|
$3.13 M
|
$9.09 M
|
$20.06 M
|
$35.58 M
|
$28.64 M
|
General & Administrative
Expenses |
$14.71 M
|
$0.00
|
$0.00
|
$27.01 M
|
$29.45 M
|
$19.63 M
|
Selling & Marketing
Expenses |
$9.41 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General &
Administrative Expenses |
$24.12 M
|
$45.31 M
|
$43.34 M
|
$27.01 M
|
$29.45 M
|
$19.63 M
|
Other Expenses |
$2.00 M |
$2.58 M |
$2.15 M |
-$38,000.00 |
-$132,000.00 |
$16,000.00 |
Operating Expenses |
$30.00 M |
$51.01 M |
$54.57 M |
$47.07 M |
$65.04 M |
$48.26 M |
Cost And Expenses |
$37.01 M |
$53.46 M |
$56.30 M |
$47.07 M |
$65.04 M |
$48.26 M |
Interest Income |
$0.00 |
$0.00 |
$1.36 M |
$0.00 |
$0.00 |
$0.00 |
Interest Expense |
$21.07 M |
$2.30 M |
$1.36 M |
$0.00 |
$0.00 |
$0.00 |
Depreciation &
Amortization |
$44.14 M
|
-$29.25 M
|
$21.58 M
|
-$28.63 M
|
$396,000.00
|
$72,000.00
|
EBITDA |
-$12.68 M
|
-$48.26 M
|
-$53.21 M
|
-$61.15 M
|
-$56.14 M
|
-$35.35 M
|
EBITDA Ratio |
-9.99 |
-44.69 |
-107.93 |
0 |
0 |
0 |
Operating Income Ratio
|
-44.77
|
-17.6
|
-151.7
|
0
|
0
|
0
|
Total Other
Income/Expenses Net |
-$1.98 M
|
-$763,000.00
|
-$1.31 M
|
-$38,000.00
|
-$8.63 M
|
-$12.82 M
|
Income Before Tax |
-$58.80 M |
-$19.77 M |
-$76.10 M |
-$32.56 M |
-$73.67 M |
-$61.08 M |
Income Before Tax Ratio
|
-46.33
|
-18.3
|
-154.36
|
0
|
0
|
0
|
Income Tax Expense |
$23.05 M |
$3.84 M |
$1.40 M |
-$14.55 M |
-$132,000.00 |
$12.84 M |
Net Income |
-$58.80 M |
-$19.77 M |
-$76.10 M |
-$18.00 M |
-$73.67 M |
-$61.08 M |
Net Income Ratio |
-46.33 |
-18.3 |
-154.36 |
0 |
0 |
0 |
EPS |
-177.3 |
-361.16 |
-5715.36 |
-2695.87 |
-11361.35 |
-9420.73 |
EPS Diluted |
-177.3 |
-361.16 |
-5715.36 |
-2695.87 |
-11361.35 |
-9420.73 |
Weighted Average Shares
Out |
$331,615.00
|
$54,738.00
|
$13,315.00
|
$6,678.00
|
$6,484.00
|
$6,484.00
|
Weighted Average Shares
Out Diluted |
$331,615.00
|
$54,738.00
|
$13,315.00
|
$6,678.00
|
$6,484.00
|
$6,484.00
|
Link |
|
|
|
|
|
|